Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MAML2 Antikörper

Dieses Maus Monoklonal-Antikörper erkennt spezifisch MAML2 in WB, IF, FACS, ISt und IHC (f). Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN6937802

Kurzübersicht für MAML2 Antikörper (ABIN6937802)

Target

Alle MAML2 Antikörper anzeigen
MAML2 (Mastermind-Like 2 (MAML2))

Reaktivität

  • 28
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Human

Wirt

  • 18
  • 11
Maus

Klonalität

  • 18
  • 11
Monoklonal

Konjugat

  • 18
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser MAML2 Antikörper ist unkonjugiert

Applikation

  • 23
  • 14
  • 10
  • 8
  • 8
  • 8
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunostaining (ISt), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Klon

MAML2-1302
  • Spezifität

    MAML2 (mastermind-like protein 2), also known as MAM2, MAM3 or MLLMAML2, is a nuclear speckle protein that acts as a transcriptional co-activator for Notch receptors. The Notch signaling pathway influences cell fate by regulating the ability of precursor cells to properly respond to developmental signals. MAML2 is a member of the mastermind-like family of proteins that are human homologs of the Drosophila melanogaster mastermind protein. Through its N-terminal region, MAML2 interacts with the ankyrin repeats of the Notch proteins Notch 1, Notch 2, Notch 3 and Notch 4. This interaction leads to formation of a DNA-binding complex with the Notch proteins and RBP-J a complex that can then induce HES1 gene expression. While the N-terminal domain of MAML2 is essential for proper Notch binding, the C-terminal domain of MAML2 is essential for transcriptional activation. A chromosomal aberration involving the gene encoding MAML2 is implicated in mucoepidermoid carcinomas, clear cell hidradenomas and benign Warthin tumors.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant human MAML2 fragment

    Isotyp

    IgG2a kappa
  • Applikationshinweise

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues is enhanced by heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0 for 45 min at 95°C followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Positive_Control: MCF-7 cells. Pancreas or Placenta. Bladder or Colon Carcinoma.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    MAML2 (Mastermind-Like 2 (MAML2))

    Andere Bezeichnung

    MAML2

    Hintergrund

    Mam-2, MAML2, Mastermind-like protein 2,MAML2 (Mastermind Like Transcriptional Coactivator 2)
    Cellular localisation: Cytoplasmic

    Molekulargewicht

    125kDa

    Gen-ID

    84441, 428214

    UniProt

    Q8IZL2
Sie sind hier:
Chat with us!